JP2012501680A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012501680A5 JP2012501680A5 JP2011527024A JP2011527024A JP2012501680A5 JP 2012501680 A5 JP2012501680 A5 JP 2012501680A5 JP 2011527024 A JP2011527024 A JP 2011527024A JP 2011527024 A JP2011527024 A JP 2011527024A JP 2012501680 A5 JP2012501680 A5 JP 2012501680A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- cells
- glycerol
- cell
- cryoprotectant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9664908P | 2008-09-12 | 2008-09-12 | |
| US61/096,649 | 2008-09-12 | ||
| PCT/US2009/056829 WO2010030986A2 (en) | 2008-09-12 | 2009-09-14 | Clean genome bactofection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012501680A JP2012501680A (ja) | 2012-01-26 |
| JP2012501680A5 true JP2012501680A5 (https=) | 2012-11-01 |
Family
ID=41328762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011527024A Pending JP2012501680A (ja) | 2008-09-12 | 2009-09-14 | クリーンゲノムバクトフェクション |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110165680A1 (https=) |
| EP (1) | EP2344646A2 (https=) |
| JP (1) | JP2012501680A (https=) |
| CA (1) | CA2736877A1 (https=) |
| WO (1) | WO2010030986A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010085539A1 (en) * | 2009-01-23 | 2010-07-29 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods and compositions based on shiga toxin type 2 protein |
| EP2742127B1 (en) * | 2011-08-12 | 2019-10-09 | Mello Biotechnology, Inc. | Inducable expression from the eukaryotic pol-2 promoter in prokaryotes |
| WO2013043459A1 (en) * | 2011-09-22 | 2013-03-28 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Shigella-derived vector and methods of using the same |
| DK2758074T3 (da) * | 2011-09-23 | 2020-07-27 | Univ Loma Linda | Bakteriestammer der udtrykker methylasegener og anvendelser deraf |
| US11680273B2 (en) | 2011-09-23 | 2023-06-20 | Loma Linda University | Treatment of autoimmune diseases |
| US10196662B2 (en) * | 2012-08-10 | 2019-02-05 | Mello Biotechnology, Inc. | Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN109312345B (zh) * | 2018-04-26 | 2021-07-20 | 广州中科蓝华生物科技有限公司 | 一种启动子及其应用 |
| CN109402155A (zh) * | 2018-11-12 | 2019-03-01 | 川北医学院 | 一种双控延迟裂解性质粒及其构建方法与应用 |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| KR20220066384A (ko) * | 2019-09-25 | 2022-05-24 | 카톨리에케 유니버시테이트 루벤 | 대형 벡터 및 고수율 제조를 위한 방법 |
| EP4103214B1 (en) | 2020-02-13 | 2026-04-29 | Tenaya Therapeutics, Inc. | Gene therapy vectors for treating heart disease |
| US20240261394A1 (en) * | 2020-05-11 | 2024-08-08 | University Of Virginia Patent Foundation | Compositions and methods for inducing immune responses against class i fusion protein viruses |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| AU2022286964A1 (en) * | 2021-06-02 | 2024-01-18 | Sivec Biotechnologies Llc | Bacterial delivery of antibodies, antibody derivatives, and polypeptides to eukaryotic cells |
| CN117771264B (zh) * | 2023-11-27 | 2024-06-25 | 山东省农业科学院畜牧兽医研究所 | circHIF1α在制备抵御细菌感染的新型疫苗中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989265B2 (en) * | 2002-01-23 | 2006-01-24 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
| US8119365B2 (en) * | 2002-01-23 | 2012-02-21 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| EP2543726B1 (en) * | 2005-08-20 | 2018-10-03 | Scarab Genomics, LLC | Reduced genome E. coli |
| US8048999B2 (en) * | 2005-12-13 | 2011-11-01 | Kyoto University | Nuclear reprogramming factor |
| EP2049668A2 (en) * | 2006-08-03 | 2009-04-22 | Wisconsin Alumni Research Foundation | Vector systems |
-
2009
- 2009-09-14 US US13/063,450 patent/US20110165680A1/en not_active Abandoned
- 2009-09-14 JP JP2011527024A patent/JP2012501680A/ja active Pending
- 2009-09-14 EP EP09792511A patent/EP2344646A2/en not_active Withdrawn
- 2009-09-14 CA CA2736877A patent/CA2736877A1/en not_active Abandoned
- 2009-09-14 WO PCT/US2009/056829 patent/WO2010030986A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501680A5 (https=) | ||
| de Figueiredo Pessôa et al. | Induced pluripotent stem cells throughout the animal kingdom: availability and applications | |
| Kaji et al. | Virus-free induction of pluripotency and subsequent excision of reprogramming factors | |
| Orkin et al. | Chromatin connections to pluripotency and cellular reprogramming | |
| Xu et al. | Genetic and epigenetic controls of plant regeneration | |
| JP2015165810A5 (https=) | ||
| Srinageshwar et al. | Role of epigenetics in stem cell proliferation and differentiation: implications for treating neurodegenerative diseases | |
| JP2018113985A5 (https=) | ||
| EP2342333A4 (en) | Method for producing induced pluripotent stem cells | |
| WO2010030986A3 (en) | Clean genome bactofection | |
| Pillai et al. | Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance | |
| CN102260646B (zh) | 一种制备诱导多潜能干细胞的方法,试剂盒及用途 | |
| JP2016535601A5 (https=) | ||
| Talluri et al. | Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons | |
| JP2015506673A5 (https=) | ||
| JP2010158171A5 (https=) | ||
| Simmet et al. | Manipulating the epigenome in nuclear transfer cloning: Where, when and how | |
| JP2024547057A5 (https=) | ||
| Rebuzzini et al. | Building pluripotency identity in the early embryo and derived stem cells | |
| Zare et al. | Epigenetic modification factors and microRNAs network associated with differentiation of embryonic stem cells and induced pluripotent stem cells toward Cardiomyocytes: a review | |
| Kim et al. | Strategy to establish embryo-derived pluripotent stem cells in cattle | |
| JP2016086744A5 (https=) | ||
| Takasato et al. | Reprogramming somatic cells to a kidney fate | |
| Wang et al. | Progress, problems and prospects of porcine pluripotent stem cells | |
| BR112014002988A2 (pt) | expressão específica de célula de proteção de transgenes em algodão |